Analysts’ Viewpoint
Percutaneous coronary intervention guidance devices are used in diagnosis and treatment of cardiovascular diseases. The global percutaneous coronary intervention guidance devices market is driven by the rise in prevalence of cardiovascular diseases, increase in awareness about early diagnosis & treatment of these diseases, and surge in demand for minimally invasive procedures, including percutaneous coronary intervention (PCI).
Growth in geriatric population, advancements in medical technology & devices, and rise in healthcare spending by government and private entities are other key factors fueling market expansion. Increase in healthcare spending and improvement in healthcare infrastructure in developing countries are anticipated to augment market development.
Growth in demand for cost-effective healthcare solutions and procedures is creating lucrative opportunities for market players. Manufacturers are focusing on advancements in technology, particularly in areas such as image guidance, real-time visualization, and improved device designs, to increase their market share.
PCI guidance devices are medical instruments used to guide catheter-based procedures to diagnose and treat heart conditions, including blocked arteries. These devices help physicians accurately navigate through blood vessels to reach the heart and deliver medications or devices, such as stents, to restore blood flow.
Usage of PCI guidance devices is increasing in the diagnosis and treatment of heart conditions such as coronary artery disease. Rise in geriatric population and growth in prevalence of cardiovascular diseases are driving market statistics.
The COVID-19 pandemic has had a significant impact on the percutaneous coronary intervention guidance devices market. PCI procedures and sales declined due to the suspension of non-emergency medical procedures amid nationwide lockdowns. However, demand for PCI guidance devices increased as the pandemic progressed, driven by the rise in number of COVID-19 patients with heart complications and need for timely diagnosis and treatment.
Minimally invasive procedures are preferred over traditional surgeries, as they result in less trauma to patients and faster recovery. PCI guidance devices help in performing these procedures with greater precision and accuracy. Rise in awareness about minimally invasive procedures among patients and healthcare providers has led to an increase in demand for PCI guidance devices.
Usage of these devices has helped reduce cost, shorten recovery time, and minimize complications. Thus, rise in demand for minimally invasive procedures in cardiovascular health is driving the percutaneous coronary intervention guidance devices market.
Rise in prevalence of cardiovascular diseases is augmenting the demand for PCI procedures, which require guidance devices to ensure the procedure's accuracy and effectiveness. Aging population and surge in unhealthy lifestyle habits are leading to an increase in incidence of cardiovascular diseases such as coronary artery disease and heart attack. This, in turn, is driving the demand for PCI procedures. PCI guidance devices provide real-time information to physicians during surgical procedures, leading to better patient outcomes.
According to the American Heart Association, cardiovascular disease is a major health issue across the world and is the leading cause of death in several countries, including the U.S. Cardiovascular diseases accounted for about one in three deaths in the country in 2020.
According to the percutaneous coronary intervention guidance devices market research, technological advancements have led to the development of more sophisticated and effective PCI guidance devices. These devices use advanced imaging techniques and navigation systems to accurately guide catheters and stents to the target area in coronary arteries, thereby improving the success rate and safety of PCI procedures.
Integration of Artificial Intelligence (AI) and Machine Learning (ML) to enhance image analysis & diagnosis accuracy, development of bioresorbable scaffolds (BRS) to reduce restenosis, and introduction of hybrid closure devices to lower vascular complications & improve procedural efficiency are the technological advancements that are likely to accelerate market progress. Furthermore, development of Fractional Flow Reserve (FFR) wire & sensor technology and integration of wearable technology to monitor patients and improve post-procedural care are projected to bolster the demand for PCI guidance devices.
In terms of product, the guide catheters segment accounted for the largest share of the global percutaneous coronary intervention guidance devices market in 2021. This can be ascribed to the ability of guide catheters to provide safe and efficient access to coronary arteries.
Advancements in guide catheter technology and design, such as better trackability and stability, have increased their popularity and usage in PCI procedures. Furthermore, surge number of PCI procedures performed globally, increase in geriatric population, and rise in incidence of cardiovascular diseases are boosting the segment.
North America dominated the percutaneous coronary intervention guidance devices global industry in 2021. Well-established healthcare infrastructure, high incidence of cardiovascular diseases, and presence of leading key players can be ascribed to the region's global dominance.
Favorable reimbursement policies for PCI procedures and rise in preference for minimally invasive procedures, including PCI, among healthcare providers are also driving the demand for PCI guidance devices in North America.
The percutaneous coronary intervention guidance devices market size in Asia Pacific is expected to grow at a rapid pace during the forecast period. Rise in awareness about advanced medical technologies and their benefits is fueling market progress in Asia Pacific.
Growth in prevalence of age-related cardiovascular diseases due to the increase in geriatric population and surge in number of hospitals and clinics, especially in countries such as China and India, is augmenting market dynamics in Asia Pacific.
Europe held significant global percutaneous coronary intervention guidance devices market share in 2021. The market in the region is driven by the increase in incidence of cardiovascular diseases, advancements in medical technology, and growth in healthcare expenditure.
This report provides profiles of leading players operating in the global percutaneous coronary intervention guidance devices market. These include Abbott, Boston Scientific Corporation, Medtronic, Johnson & Johnson Services, Inc., Terumo Corporation, Biosensors International Group, Ltd., B. Braun SE, Cordis, Meril Life Sciences Pvt. Ltd., CONMED Corporation, Emirates Health Services (EHS), and Koninklijke Philips N.V.
Prominent players are engaging in mergers & acquisitions, strategic collaborations, and new product launches to expand their presence and increase market share.
Leading players have been profiled in the percutaneous coronary intervention guidance devices market report based on parameters such as company overview, financial overview, strategies, portfolio, segments, and recent developments.
|
Attribute |
Detail |
|
Size in 2021 |
US$ 12.2 Bn |
|
Forecast (Value) in 2031 |
More than US$ 23.5 Bn |
|
Growth Rate (CAGR) |
6.1% |
|
Forecast Period |
2022–2031 |
|
Historical Data Available for |
2017–2021 |
|
Quantitative Units |
US$ Bn for Value |
|
Market Analysis |
It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
The global industry was valued at US$ 12.2 Bn in 2021.
It is projected to reach more than US$ 23.5 Bn by 2031.
The CAGR is anticipated to be 6.1% from 2022 to 2031.
The guide catheters segment accounted for more than 50.0% share in 2021.
North America is expected to hold significant share during the forecast period.
Abbott, Boston Scientific Corporation, Medtronic, Johnson & Johnson Services, Inc., Terumo Corporation, Biosensors International Group, Ltd., B. Braun SE, Cordis, Meril Life Sciences Pvt. Ltd., CONMED Corporation, Emirates Health Services (EHS), and Koninklijke Philips N.V.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Percutaneous Coronary Intervention Guidance Devices Market
4. Market Overview
4.1. Introduction
4.1.1. Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Percutaneous Coronary Intervention Guidance Devices Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
4.4.2. Market Volume/Unit Shipments Projections
4.5. Porter’s Five Force Analysis
5. Key Insights
5.1. Key Mergers & Acquisitions
5.2. Technologiacal Advancements
5.3. Disease Prevalence & Incidence Rate globally with key countries
5.4. Regulatory Scenario by Region/globally
5.5. COVID 19 Impact on Industry
6. Percutaneous Coronary Intervention Guidance Devices Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2017–2031
6.3.1. Percutaneous Sheath Introducers
6.3.2. Guide Catheters
6.3.3. Guidewires
6.3.4. Others
6.4. Market Attractiveness Analysis, by Product
7. Percutaneous Coronary Intervention Guidance Devices Market Analysis and Forecast, by Indication
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Indication, 2017–2031
7.3.1. Myocardial Infarction
7.3.2. Acute Coronary Syndrome
7.3.3. Others
7.4. Market Attractiveness Analysis, by Indication
8. Percutaneous Coronary Intervention Guidance Devices Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Ambulatory Surgical Centers
8.3.3. Others
8.4. Market Attractiveness Analysis, by End-user
9. Percutaneous Coronary Intervention Guidance Devices Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Respiratory Disposables Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2017–2031
10.2.1. Percutaneous Sheath Introducers
10.2.2. Guide Catheters
10.2.3. Guidewires
10.2.4. Others
10.3. Market Value Forecast, by Indication, 2017–2031
10.3.1. Myocardial Infarction
10.3.2. Acute Coronary Syndrome
10.3.3. Others
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Hospitals
10.4.2. Ambulatory Surgical Centers
10.4.3. Others
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Indication
10.6.3. By End-user
10.6.4. By Country
11. Europe Respiratory Disposables Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017–2031
11.2.1. Percutaneous Sheath Introducers
11.2.2. Guide Catheters
11.2.3. Guidewires
11.2.4. Others
11.3. Market Value Forecast, by Indication, 2017–2031
11.3.1. Myocardial Infarction
11.3.2. Acute Coronary Syndrome
11.3.3. Others
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Hospitals
11.4.2. Ambulatory Surgical Centers
11.4.3. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Indication
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Respiratory Disposables Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017–2031
12.2.1. Percutaneous Sheath Introducers
12.2.2. Guide Catheters
12.2.3. Guidewires
12.2.4. Others
12.3. Market Value Forecast, by Indication, 2017–2031
12.3.1. Myocardial Infarction
12.3.2. Acute Coronary Syndrome
12.3.3. Others
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Hospitals
12.4.2. Ambulatory Surgical Centers
12.4.3. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Indication
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Respiratory Disposables Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017–2031
13.2.1. Percutaneous Sheath Introducers
13.2.2. Guide Catheters
13.2.3. Guidewires
13.2.4. Others
13.3. Market Value Forecast, by Indication, 2017–2031
13.3.1. Myocardial Infarction
13.3.2. Acute Coronary Syndrome
13.3.3. Others
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Hospitals
13.4.2. Ambulatory Surgical Centers
13.4.3. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Indication
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Respiratory Disposables Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product, 2017–2031
14.2.1. Percutaneous Sheath Introducers
14.2.2. Guide Catheters
14.2.3. Guidewires
14.2.4. Others
14.3. Market Value Forecast, by Indication, 2017–2031
14.3.1. Myocardial Infarction
14.3.2. Acute Coronary Syndrome
14.3.3. Others
14.4. Market Value Forecast, by End-user, 2017–2031
14.4.1. Hospitals
14.4.2. Ambulatory Surgical Centers
14.4.3. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product
14.6.2. By Indication
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2021
15.3. Company Profiles
15.3.1. Abbott
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. Financial Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. Boston Scientific Corporation
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. Medtronic
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. Johnson & Johnson Services, Inc.
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. Terumo Corporation
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Portfolio
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. Biosensors International Group, Ltd.
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Portfolio
15.3.6.3. Financial Overview
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. B. Braun SE
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Portfolio
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. Cordis
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. Financial Overview
15.3.8.4. SWOT Analysis
15.3.8.5. Strategic Overview
15.3.9. Meril Life Sciences Pvt. Ltd.
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Portfolio
15.3.9.3. Financial Overview
15.3.9.4. SWOT Analysis
15.3.9.5. Strategic Overview
15.3.10. CONMED Corporation
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Product Portfolio
15.3.10.3. Financial Overview
15.3.10.4. SWOT Analysis
15.3.10.5. Strategic Overview
15.3.11. Koninklijke Philips N.V.
15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.11.2. Product Portfolio
15.3.11.3. Financial Overview
15.3.11.4. SWOT Analysis
15.3.12. Emirates Health Services (EHS)
15.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.12.2. Product Portfolio
15.3.12.3. Financial Overview
15.3.12.4. SWOT Analysis
15.3.12.5. Strategic Overview
List of Tables
Table 01: Global Percutaneous Coronary Intervention Guidance Devices Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 02: Global Percutaneous Coronary Intervention Guidance Devices Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 03: Global Percutaneous Coronary Intervention Guidance Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 04: Global Percutaneous Coronary Intervention Guidance Devices Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 05: North America Percutaneous Coronary Intervention Guidance Devices Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 06: North America Percutaneous Coronary Intervention Guidance Devices Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 07: North America Percutaneous Coronary Intervention Guidance Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 08: North America Percutaneous Coronary Intervention Guidance Devices Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 09: Europe Percutaneous Coronary Intervention Guidance Devices Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 10: Europe Percutaneous Coronary Intervention Guidance Devices Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 11: Europe Percutaneous Coronary Intervention Guidance Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 12: Europe Percutaneous Coronary Intervention Guidance Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 13: Asia Pacific Percutaneous Coronary Intervention Guidance Devices Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 14: Asia Pacific Percutaneous Coronary Intervention Guidance Devices Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 15: Asia Pacific Percutaneous Coronary Intervention Guidance Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 16: Asia Pacific Percutaneous Coronary Intervention Guidance Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 17: Latin America Percutaneous Coronary Intervention Guidance Devices Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 18: Latin America Percutaneous Coronary Intervention Guidance Devices Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 19: Latin America Percutaneous Coronary Intervention Guidance Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 20: Latin America Percutaneous Coronary Intervention Guidance Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 21: Middle East & Africa Percutaneous Coronary Intervention Guidance Devices Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 22: Middle East & Africa Percutaneous Coronary Intervention Guidance Devices Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 23: Middle East & Africa Percutaneous Coronary Intervention Guidance Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 24: Middle East & Africa Percutaneous Coronary Intervention Guidance Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
List of Figures
Figure 01: Global Percutaneous Coronary Intervention Guidance Devices Market Value (US$ Mn) Forecast, 2017–2031
Figure 02: Global Percutaneous Coronary Intervention Guidance Devices Market Value Share Analysis, by Product, 2021 and 2031
Figure 03: Global Percutaneous Coronary Intervention Guidance Devices Market Attractiveness Analysis, by Product, 2022–2031
Figure 04: Global Percutaneous Cronary Intervention Guidance Devices Market Value Share Analysis, by Indication, 2021 and 2031
Figure 05: Global Percutaneous Coronary Intervention Guidance Devices Market Attractiveness Analysis, by Indication, 2022–2031
Figure 06: Global Percutaneous Coronary Intervention Guidance Devices Market Value Share Analysis, by End-user, 2021 and 2031
Figure 07: Global Percutaneous Coronary Intervention Guidance Devices Market Attractiveness Analysis, by End-user, 2022–2031
Figure 08: Global Percutaneous Coronary Intervention Guidance Devices Market Value Share Analysis, by Region, 2021 and 2031
Figure 09: Global Percutaneous Coronary Intervention Guidance Devices Market Attractiveness Analysis, by Region, 2022–2031
Figure 10: North America Percutaneous Coronary Intervention Guidance Devices Market Value (US$ Mn) Forecast, 2017–2031
Figure 11: North America Percutaneous Coronary Intervention Guidance Devices Market Value Share Analysis, by Product, 2021 and 2031
Figure 12: North America Percutaneous Coronary Intervention Guidance Devices Market Attractiveness Analysis, by Product, 2022–2031
Figure 13: North America Percutaneous Coronary Intervention Guidance Devices Market Value Share Analysis, by Indication, 2021 and 2031
Figure 14: North America Percutaneous Coronary Intervention Guidance Devices Market Attractiveness Analysis, by Indication, 2022–2031
Figure 15: North America Percutaneous Coronary Intervention Guidance Devices Market Value Share Analysis, by End-user, 2021 and 2031
Figure 16: North America Percutaneous Coronary Intervention Guidance Devices Market Attractiveness Analysis, by End-user, 2022–2031
Figure 17: North America Percutaneous Coronary Intervention Guidance Devices Market Value Share Analysis, by Country, 2021 and 2031
Figure 18: North America Percutaneous Coronary Intervention Guidance Devices Market Attractiveness Analysis, by Country, 2022–2031
Figure 19: Europe Percutaneous Coronary Intervention Guidance Devices Market Value (US$ Mn) Forecast, 2017–2031
Figure 20: Europe Percutaneous Coronary Intervention Guidance Devices Market Value Share Analysis, by Product, 2021 and 2031
Figure 21: Europe Percutaneous Coronary Intervention Guidance Devices Market Attractiveness Analysis, by Product, 2022–2031
Figure 22: Europe Percutaneous Coronary Intervention Guidance Devices Market Value Share Analysis, by Indication, 2021 and 2031
Figure 23: Europe Percutaneous Coronary Intervention Guidance Devices Market Attractiveness Analysis, by Indication, 2022–2031
Figure 24: Europe Percutaneous Coronary Intervention Guidance Devices Market Value Share Analysis, by End-user, 2021 and 2031
Figure 25: Europe Percutaneous Coronary Intervention Guidance Devices Market Attractiveness Analysis, by End-user, 2022–2031
Figure 26: Europe Percutaneous Coronary Intervention Guidance Devices Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 27: Europe Percutaneous Coronary Intervention Guidance Devices Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 28: Asia Pacific Percutaneous Coronary Intervention Guidance Devices Market Value (US$ Mn) Forecast, 2017–2031
Figure 29: Asia Pacific Percutaneous Coronary Intervention Guidance Devices Market Value Share Analysis, by Product, 2021 and 2031
Figure 30: Asia Pacific Percutaneous Coronary Intervention Guidance Devices Market Attractiveness Analysis, by Product, 2022–2031
Figure 31: Asia Pacific Percutaneous Coronary Intervention Guidance Devices Market Value Share Analysis, by Indication, 2021 and 2031
Figure 32: Asia Pacific Percutaneous Coronary Intervention Guidance Devices Market Attractiveness Analysis, by Indication, 2022–2031
Figure 33: Asia Pacific Percutaneous Coronary Intervention Guidance Devices Market Value Share Analysis, by End-user, 2021 and 2031
Figure 34: Asia Pacific Percutaneous Coronary Intervention Guidance Devices Market Attractiveness Analysis, by End-user, 2022–2031
Figure 35: Asia Pacific Percutaneous Coronary Intervention Guidance Devices Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 36: Asia Pacific Percutaneous Coronary Intervention Guidance Devices Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 37: Latin America Percutaneous Coronary Intervention Guidance Devices Market Value (US$ Mn) Forecast, 2017–2031
Figure 38: Latin America Percutaneous Coronary Intervention Guidance Devices Market Value Share Analysis, by Product, 2021 and 2031
Figure 39: Latin America Percutaneous Coronary Intervention Guidance Devices Market Attractiveness Analysis, by Product, 2022–2031
Figure 40: Latin America Percutaneous Coronary Intervention Guidance Devices Market Value Share Analysis, by Indication, 2021 and 2031
Figure 41: Latin America Percutaneous Coronary Intervention Guidance Devices Market Attractiveness Analysis, by Indication, 2022–2031
Figure 42: Latin America Percutaneous Coronary Intervention Guidance Devices Market Value Share Analysis, by End-user, 2021 and 2031
Figure 43: Latin America Percutaneous Coronary Intervention Guidance Devices Market Attractiveness Analysis, by End-user, 2022–2031
Figure 44: Latin America Percutaneous Coronary Intervention Guidance Devices Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 45: Latin America Percutaneous Coronary Intervention Guidance Devices Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 46: Middle East & Africa Percutaneous Coronary Intervention Guidance Devices Market Value (US$ Mn) Forecast, 2017–2031
Figure 47: Middle East & Africa Percutaneous Coronary Intervention Guidance Devices Market Value Share Analysis, by Product, 2021 and 2031
Figure 48: Middle East & Africa Percutaneous Coronary Intervention Guidance Devices Market Attractiveness Analysis, by Product, 2022–2031
Figure 49: Middle East & Africa Percutaneous Coronary Intervention Guidance Devices Market Value Share Analysis, by Indication, 2021 and 2031
Figure 50: Middle East & Africa Percutaneous Coronary Intervention Guidance Devices Market Attractiveness Analysis, by Indication, 2022–2031
Figure 51: Middle East & Africa Percutaneous Coronary Intervention Guidance Devices Market Value Share Analysis, by End-user, 2021 and 2031
Figure 52: Middle East & Africa Percutaneous Coronary Intervention Guidance Devices Market Attractiveness Analysis, by End-user, 2022–2031
Figure 53: Middle East & Africa Percutaneous Coronary Intervention Guidance Devices Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 54: Middle East & Africa Percutaneous Coronary Intervention Guidance Devices Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 55: Global Percutaneous Coronary Intervention Guidance Devices Market Share Analysis, by Company, 2021
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Percutaneous Coronary Intervention Guidance Devices Market
